Overview

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label Phase II randomized pre-surgical pharmacodynamics study.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Letrozole